Risk factors and cumulative incidence of anaemia among human immunodeficiency virus-infected children in Uganda
暂无分享,去创建一个
R. Semba | J. Jackson | C. Ndugwa | F. Mmiro | G. Melikian | T. Clark | T. D. Clark | R. Perry
[1] N. Michael,et al. Joint United Nations Programme on HIV/AIDS. , 2004, Military medicine.
[2] R. Semba,et al. Iron supplementation during human immunodeficiency virus infection: a double-edged sword? , 2001, Medical hypotheses.
[3] G. Gray,et al. Pathogenesis of Anemia During Human Immunodeficiency Virus Infection , 2001, Journal of Investigative Medicine.
[4] E. Pollitt. The developmental and probabilistic nature of the functional consequences of iron-deficiency anemia in children. , 2001, The Journal of nutrition.
[5] Z. Premji,et al. An analysis of anemia and child mortality. , 2001, The Journal of nutrition.
[6] M. Quigley,et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study , 2000, The Lancet.
[7] P. Volberding,et al. Consensus statement: anemia in HIV infection--current trends, treatment options, and practice strategies. Anemia in HIV Working Group. , 2000, Clinical therapeutics.
[8] L. Mofenson,et al. Advances and research directions in the prevention of mother-to-child HIV-1 transmission , 2000, The Lancet.
[9] M. Parker,et al. HIV and Infant Feeding. (World Health Organization, Joint United Nations Programme on HIV/AIDS (UNAIDS) and United Nations Children's Fund, 1998.) US $14.40. , 2000 .
[10] G. Pescarmona,et al. Iron metabolism and HIV infection: reciprocal interactions with potentially harmful consequences? , 1999, Cell biochemistry and function.
[11] Dorothy Bray,et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial , 1999, The Lancet.
[12] R. Moore,et al. Human immunodeficiency virus infection, anemia, and survival. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] S. Diop,et al. [Hematologic abnormalities and immunodepression in HIV/AIDS- related pulmonary tuberculosis]. , 1999, Bulletin de la Societe de pathologie exotique.
[14] L. Sacks,et al. Factors related to in-hospital deaths in patients with tuberculosis. , 1998, Archives of internal medicine.
[15] W. Andiman,et al. Development of a prognosis-based clinical staging system for infants infected with human immunodeficiency virus. , 1996, The Journal of pediatrics.
[16] E. Weinberg,et al. Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. , 1996, Infectious agents and disease.
[17] L. Kalish,et al. Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group. , 1996, The Journal of pediatrics.
[18] J. Adewuyi,et al. Haematologic features of the human immunodeficiency virus (HIV) infection in Black children in Harare. , 1994, The Central African journal of medicine.
[19] A. Rubinstein,et al. Hematologic manifestations in pediatric HIV infection: severe anemia as a prognostic factor. , 1990, The American journal of pediatric hematology/oncology.
[20] H. Nell,et al. The haematological and biochemical changes in severe pulmonary tuberculosis. , 1989, The Quarterly journal of medicine.
[21] J. Phair,et al. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. , 1987, The New England journal of medicine.
[22] K Y Liang,et al. Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.
[23] G. Cartwright,et al. The anemia of infection. XIX. Studies on free erythrocyte coproporphyrin and protoporphyrin. , 1954, Blood.